RxDoctor Payments Data

Carmelita Swiner

Family Medicine · Durham, NCNPI 1487874442

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by GSK at 32.6% of the total. Reporting peaked in 2019 at $817 and has fallen 94.0% since, to $49 in 2024.

$1,119in general payments, 2019–2025

Across 31 payments — averaging $36.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$365
  • AbbVie$340
  • Johnson & Johnson$97
  • Pfizer$63
  • Boston Scientific$49
  • Boehringer Ingelheim$33
  • plus $173 from 11 others
$247,697in research payments, 2019–2025

Across 6 payments — averaging $41,283 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bavarian Nordic A/s$248K

What the payments were for

  • Consulting fees$66559%
  • Food & beverage$45441%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,119 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Other family medicine in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →